Earnings Call · Q4 FY2021·2022-02-26

Q4 21EPS 0.00%·Rev n/aQ3 21EPS -20.00%·Rev n/aQ2 21EPS -100.00%*·Rev n/aQ1 21EPS -100.00%*·Rev n/a⚠ consensus missing

Nautilus Biotechnology, Inc. NAUT

Unidentified Company Representative — Investor Relations or Corporate Communications Representative

Sujal Patel — Chief Executive Officer

Parag Mallick — Co-founder and Chief Scientific Officer

Anna Mowry — Chief Financial Officer

+8.4%1d on move date+6.9% vs SPY3d+12.4%5d+4.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAUT calls or request research access.

More NAUT calls Browse calls Request research access